Probiotic consumption and hepatic steatosis: results from the NHANES 2011–2016 and Mendelian randomization study

Abstract excerpt

Background: Recent research showed that probiotics treatment may reduce insulin resistance, regulate lipid metabolism, raise liver enzyme levels, and ameliorate inflammation in individuals with metabolic associated fatty liver disease (MAFLD). However, the possible effects of probiotic use on the progression of hepatic steatosis (HS) have not been identified. The purpose of this study was to investigate this in a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diet, Metabolism, and Disease
• Share to Gut microbiota and health
• Share to Liver Disease Diagnosis and Treatment